Hemogenyx Pharmaceuticals achieves new milestone with patient recruitment for first clinical trial

By Proactive Investors / January 02, 2025 / www.youtube.com / Article Link

Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) CEO Dr Vladislav Sandler talked with Proactive's Stephen Gunnion ...

Recent News

Gold stocks rise but lag broader equity gains

January 20, 2025 / www.canadianminingreport.com

Wesdome, Seabridge and Skeena report outstanding drill results

January 20, 2025 / www.canadianminingreport.com

Smaller juniors still financed even in more cautious market

January 13, 2025 / www.canadianminingreport.com

Gold stocks shrug off equity market decline on metal gain

January 13, 2025 / www.canadianminingreport.com

Geopolitical risk outlook unclear after US election

January 06, 2025 / www.canadianminingreport.com

See all >